Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular Mechanisms of DTH and Prednisone Effect
NCT03625219Phase 1Completed
- Sponsor
- Innovaderm Research
- Start
- Jul 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of prednisone in delayed-type hypersensitivity (DTH) (3 arms), sponsored by Innovaderm Research. Primary endpoints: Gene expression levels in skin biopsies, Epidermal thickness in skin biopsies and 1 more. Started Jul 2018; status: completed.
02
Drugs
prednisone
03
Conditions
delayed-type hypersensitivity (DTH)
Beyond the preview
Go deeper on NCT03625219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03625219.